Hypoxia-activated prodrugs and (lack of) clinical progress:...

Clinical and Translational Radiation Oncology 2019 / 02 Vol. 15

Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials

Spiegelberg, Linda, Houben, Ruud, Niemans, Raymon, de Ruysscher, Dirk, Yaromina, Ala, Theys, Jan, Guise, Christopher P., Smaill, Jeffrey B., Patterson, Adam V., Lambin, Philippe, Dubois, Ludwig J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Language:
english
Journal:
Clinical and Translational Radiation Oncology
DOI:
10.1016/j.ctro.2019.01.005
Date:
February, 2019
File:
PDF, 518 KB
english, 2019
Conversion to is in progress
Conversion to is failed